Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Hepato-Biliary-Pancreatic Sciences|September 13, 2021
Current status and future perspectives of clinical research in pancreatic cancer: Establishment of evidence by scienceNing Pu, Hanlin Yin, Qiangda Chen, et al.
Critical Reviews in Oncology/Hematology|December 6, 2023
Cancer-associated fibroblasts in neoadjuvant setting for solid cancersYanan Gu, Qiangda Chen, Hanlin Yin, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 10, 2025
The CD39-CD73-adenosine axis: Master regulator of immune evasion and therapeutic target in pancreatic ductal adenocarcinomaXiaolong Liu, Qingzhu Ding, Han Zhang, et al.
Cancer Science|August 17, 2021
Chemokine C-C motif ligand 21 synergized with programmed death-ligand 1 blockade restrains tumor growthQiangda Chen, Hanlin Yin, Ning Pu, et al.
Experimental Biology and Medicine (Maywood, N.J.)|October 11, 2021
A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancerQiangda Chen, Ning Pu, Hanlin Yin, et al.
Journal of Zhejiang University. Science. B|December 14, 2021
Basophils as a potential therapeutic target in cancerJicheng Zhang, Hanlin Yin, Qiangda Chen, et al.
Journal of Cellular and Molecular Medicine|July 10, 2020
CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancerQiangda Chen, Ning Pu, Hanlin Yin, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 21, 2022
Identification of an Immune-Related BAT Signature for Predicting Adjuvant Chemotherapy Response and Overall Survival in Patients with Resected Ductal Adenocarcinoma of the PancreasNing Pu, Qiangda Chen, Hanlin Yin, et al.
Pageof 3